ArticleThe Journal of clinical investigation2021

Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.

Tayyab Rehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.